Mr. Luttrell (for himself, Mr. McCaul, Mr. Bergman, and Mr. Correa) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act. H.R. 9559. 119th
Cong., 2nd
sess., Introduced in House June 30, 2026. https://www.govinfo.gov/app/details/BILLS-119hr9559ih.
APA
Congress, House of Representatives (2026, June 30). Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act (H.R. 9559 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119hr9559ih.
MLA
United States, Congress, House of Representatives. Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119hr9559ih. 119th Congress, H.R. 9559, Introduced in House 30 Jun. 2026.
Bluebook
H.R.9559 - 119th Congress (2025-2026): Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act, H.R.9559, 119th Cong. (2026), https://www.govinfo.gov/app/details/BILLS-119hr9559ih.
